Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

Employees:
510
Market Cap:
$5.93 billion
Revenue:
$47.08 million
5 Year Trend:
10.6%
Net Income:
$-420.97 million
NASDAQ:
ALNY

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Wikipedia

Alnylam Pharmaceuticals

Employees:
510
Market Cap:
$5.93 billion
Revenue:
$47.08 million
5 Year Trend:
10.6%
Net Income:
$-420.97 million
NASDAQ:
ALNY

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. Wikipedia

2 jobs at Alnylam Pharmaceuticals

Jobs in
Page 1 2